Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
May 17, 2024
We are exhibiting at BIO 2024! Come visit our booth #4952
We are exhibiting at BIO 2024!
Come visit our booth #4952 and see how we’re empowering the industry to stand up for science. See you on the floor in San Diego, June 3-6
Meet with our team Manoj Vyas, Dr. Sandeep Singh, Jaimeen Vanparia, Devang Pandya
For business appointments please email us at devang.pandya@cbcc.global
For more details about this conference, please visit: https://convention.bio.org/